Amplify Seymour Cannabis ETF
|
||||||||
Schedule of Investments
|
||||||||
January 31, 2024 (Unaudited)
|
||||||||
COMMON STOCKS - 35.1%
|
Shares
|
Value
|
||||||
Consumer Discretionary - 3.7%
|
||||||||
GrowGeneration Corp.(a)
|
515,694
|
$
|
1,191,253
|
|||||
Consumer Staples - 1.5%
|
||||||||
Neptune Wellness Solutions, Inc.(a)(b)
|
0
|
0
|
||||||
Village Farms International, Inc.(a)(c)
|
580,778
|
493,661
|
||||||
493,661
|
||||||||
Financials - 2.0%
|
||||||||
Silver Spike Investment Corp.
|
82,918
|
638,469
|
||||||
Health Care - 19.1%
|
||||||||
Aleafia Health, Inc.(a)(b)(d)
|
80,872
|
0
|
||||||
Auxly Cannabis Group, Inc.(a)
|
3,137,044
|
35,000
|
||||||
Canopy Growth Corp.(a)(c)
|
36,276
|
169,409
|
||||||
Cara Therapeutics, Inc.(a)
|
65,538
|
37,068
|
||||||
cbdMD, Inc.(a)
|
1
|
1
|
||||||
Charlotte's Web Holdings, Inc.(a)(c)
|
1,102,907
|
196,882
|
||||||
Clever Leaves Holdings, Inc.(a)
|
5,093
|
13,242
|
||||||
Cronos Group, Inc.(a)
|
595,463
|
1,190,926
|
||||||
Jazz Pharmaceuticals PLC(a)
|
553
|
67,864
|
||||||
MediPharm Labs Corp.(a)
|
2,927,844
|
152,441
|
||||||
Organigram Holdings, Inc.(a)(c)
|
169,800
|
281,868
|
||||||
SNDL, Inc.(a)
|
298,791
|
397,392
|
||||||
TerrAscend Corp.(a)
|
780,700
|
1,550,425
|
||||||
Tilray Brands, Inc.(a)(c)
|
1,168,784
|
2,138,874
|
||||||
6,231,392
|
||||||||
Industrials - 0.5%
|
||||||||
Hydrofarm Holdings Group, Inc.(a)
|
171,646
|
169,930
|
||||||
Information Technology - 3.0%
|
||||||||
Akerna Corp.(a)
|
1
|
0
|
||||||
WM Technology, Inc.(a)
|
1,214,393
|
984,873
|
||||||
984,873
|
||||||||
Real Estate - 5.3%
|
||||||||
Innovative Industrial Properties, Inc.(e)
|
18,424
|
1,717,669
|
||||||
TOTAL COMMON STOCKS (Cost $70,058,802)
|
11,427,247
|
|||||||
RIGHTS - 0.0%(f)
|
Contracts
|
|||||||
Harmony Biosciences Holdings, Inc.(a)(d)
|
220,858
|
0
|
||||||
TOTAL RIGHTS (Cost $0)
|
0
|
|||||||
SHORT-TERM INVESTMENTS - 21.1%
|
||||||||
Investments Purchased with Proceeds
from Securities Lending - 9.1%
|
||||||||
First American Government Obligations Fund - Class X, 5.18%(g)
|
2,979,665
|
2,979,665
|
||||||
Money Market Funds - 12.0%
|
||||||||
Invesco Government & Agency Portfolio – Institutional Class, 5.25%(g)
|
3,906,469
|
3,906,469
|
||||||
TOTAL SHORT-TERM INVESTMENTS
(Cost $6,886,134)
|
6,886,134
|
|||||||
TOTAL INVESTMENTS - 56.2% (Cost
$76,944,936)
|
18,313,381
|
|||||||
Other Assets in Excess of Liabilities - 43.8%
|
14,252,592
|
|||||||
TOTAL NET ASSETS - 100.0%
|
$
|
32,565,973
|
Percentages are stated as a percent of net assets.
|
|
The Global Industry Classification Standard (GICS®) was developed by and/or is the exclusive property of MSCI, Inc. and
Standard & Poor’s Financial Services LLC (“S&P”). GICS is a service mark of MSCI, Inc. and S&P and has been licensed for use by U.S. Bank Global Fund Services.
|
PLC - Public Limited Company
|
(a)
|
Non-income producing security.
|
(b)
|
Less than $0.50.
|
(c)
|
All or a portion of this security is on loan as of January 31, 2024. The total market value of these securities was $2,619,923
which represented 8.0% of net assets.
|
(d)
|
Fair value determined using significant unobservable inputs in accordance with procedures established by and under the supervision
of the Adviser, acting as Valuation Designee. These securities represented $0 or 0.0% of net assets as of January 31, 2024.
|
(e)
|
Real Estate Investment Trust.
|
(f)
|
Represents less than 0.05% of net assets.
|
(g)
|
The rate shown represents the 7-day effective yield as of January 31, 2024.
|
Reference Index
|
Counterparty
|
Long/Short
|
Expiration Date
|
Financing Rate (a)
|
Payment Frequency
|
Notional Amount
|
Value/Unrealized Appreciation (Depreciation)
|
|||||||||
Ayr Wellness, Inc.
|
Nomura Global Financing Productions, Inc.
|
Long
|
5/28/2024
|
6.81
|
Monthly
|
$
|
847,394
|
$
|
117,443
|
|||||||
Cannabist Company
|
Nomura Global Financing Productions, Inc
|
Long
|
5/28/2024
|
6.81
|
Monthly
|
13,808
|
(13,471
|
)
|
||||||||
Cresco Lab, Inc.
|
Nomura Global Financing Productions, Inc
|
Long
|
5/28/2024
|
6.81
|
Monthly
|
2,142,004
|
(94,500
|
)
|
||||||||
Curaleaf Holdings, Inc.
|
Nomura Global Financing Productions, Inc
|
Long
|
5/28/2024
|
6.81
|
Monthly
|
4,435,981
|
322,309
|
|||||||||
Green Thumb Industries, Inc.
|
Nomura Global Financing Productions, Inc
|
Long
|
5/28/2024
|
6.81
|
Monthly
|
5,180,030
|
35,345
|
|||||||||
Truelieve Cannabis Corp.
|
Nomura Global Financing Productions, Inc
|
Long
|
5/28/2024
|
6.81
|
Monthly
|
4,054,254
|
1,092,697
|
|||||||||
Verano Holdings Corp.
|
Nomura Global Financing Productions, Inc
|
Long
|
5/28/2024
|
6.81
|
Monthly
|
3,278,517
|
372,808
|
|||||||||
$
|
1,832,631
|
(a)
|
Financing rate based on the overnight bank rate plus a spread of 150 basis points and is reset monthly.
|
Amplify Seymour Cannabis ETF
|
||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
Assets:
|
||||||||||||||||
Common Stocks
|
||||||||||||||||
Consumer Discretionary
|
$
|
1,191,253
|
$
|
–
|
$
|
–
|
$
|
1,191,253
|
||||||||
Consumer Staples
|
493,661
|
–
|
–
|
493,661
|
||||||||||||
Financials
|
638,469
|
–
|
–
|
638,469
|
||||||||||||
Health Care
|
6,231,392
|
–
|
0
|
6,231,392
|
||||||||||||
Industrials
|
169,930
|
–
|
–
|
169,930
|
||||||||||||
Information Technology
|
984,873
|
–
|
–
|
984,873
|
||||||||||||
Real Estate
|
1,717,669
|
–
|
–
|
1,717,669
|
||||||||||||
Common Stocks - Total
|
$
|
11,427,247
|
$
|
–
|
$
|
–
|
$
|
11,427,247
|
||||||||
Rights
|
–
|
–
|
0
|
–
|
||||||||||||
Investments Purchased with Proceeds from Securities Lending
|
2,979,665
|
–
|
–
|
2,979,665
|
||||||||||||
Money Market Funds
|
3,906,469
|
–
|
–
|
3,906,469
|
||||||||||||
Total Assets
|
$
|
18,313,381
|
$
|
–
|
$
|
0
|
$
|
18,313,381
|
||||||||
Other Financial Instruments:*
|
||||||||||||||||
Assets
|
||||||||||||||||
Total Return Swaps
|
$
|
–
|
$
|
1,940,602
|
$
|
–
|
$
|
1,940,602
|
||||||||
Total Assets
|
$
|
–
|
$
|
1,940,602
|
$
|
–
|
$
|
1,940,602
|
||||||||
Liabilities
|
||||||||||||||||
Total Return Swaps
|
$
|
–
|
$
|
107,971
|
$
|
–
|
$
|
107,971
|
||||||||
Total Liabilities
|
$
|
–
|
$
|
107,971
|
$
|
–
|
$
|
107,971
|
||||||||
* The fair value of the Fund's investment represents the net unrealized appreciation (depreciation) as of January 31, 2024.
|
||||||||||||||||
Refer to the Schedule of Investments for industry classifications.
|
||||||||||||||||